• Sections
  • Newsletters
  • Podcasts
  • Support TPM
  • Shop Merch
  • Site Info
  • About
  • Sections
  • Editors' Blog
  • News
  • Live Blog
  • Cafe
  • Muckraker
  • Morning Memo
  • Where Things Stand
  • The Weekender
  • Features
  • Support TPM
  • Memberships
  • The TPM Journalism Fund
  • Site Info
  • FAQ
  • Contact
  • Advertise
  • Terms
  • Privacy
  • Site Status
  • About
  • About TPM
  • Mission
  • Masthead
  • Financials
  • Careers
  • Pitch Us
Follow TPM
© 2026 TPM MEDIA LLC. ALL RIGHTS RESERVED.
Talking Points Memo Logo
Send Tips TPM 25th Anniversary Badge
vaccines
Biden Asserts Every American Will Have Access To COVID Vaccine ‘By The End Of July’
By Zoe Richards
02.17.21 | 8:14 am
Fauci Denigrates Trump Admin’s ‘Rather Vague’ Vaccine Rollout Plan
By Zoe Richards
02.16.21 | 1:39 pm
in Super Bowl LII at U.S. Bank Stadium on February 4, 2018 in Minneapolis, Minnesota. in Super Bowl LII at U.S. Bank Stadium on February 4, 2018 in Minneapolis, Minnesota.
Biden Hopes To Convert Anti-Maskers In Super Bowl Video Message
By Zoe Richards
02.05.21 | 10:40 am
Trump’s WH Was A COVID Hot Zone. Biden WH Has Now Vaccinated Hundreds Of Staffers.
By Zoe Richards
01.26.21 | 12:15 pm
Klain Lays Out Biden Admin’s ‘Federally Led Effort’ On COVID Vaccines
By Zoe Richards
01.22.21 | 11:48 am
How Many Vaccine Shots Go to Waste? Several States Aren’t Counting.
By Ryan Gabrielson Caroline Chen And Mollie Simon
01.21.21 | 8:01 am
AURORA, CO - DECEMBER 15: Rocky Mountain Regional VA Medical Center investigational pharmacy technician Sara Berech holds a dose of the Johnson & Johnson COVID-19 vaccine before it is administered in a clinical trial on December 15, 2020 in Aurora, Colorado. The Johnson & Johnson vaccine could be submitted for emergency use by late January and is the only vaccine among leading candidates given as a single dose. (Photo by Michael Ciaglo/Getty Images) AURORA, CO - DECEMBER 15: Rocky Mountain Regional VA Medical Center investigational pharmacy technician Sara Berech holds a dose of the Johnson & Johnson COVID-19 vaccine before it is administered in a clinical trial on December 15, 2020 in Aurora, Colorado. The Johnson & Johnson vaccine could be submitted for emergency use by late January and is the only vaccine among leading candidates given as a single dose. (Photo by Michael Ciaglo/Getty Images)
Report: Biden Admin Discovers Trump Had Zero Plans For COVID Vaccine Distribution
By Cristina Cabrera
01.21.21 | 7:51 am
Biden: No Trust For Trump On COVID-19 Vaccine
By Josh Kovensky
09.16.20 | 4:42 pm
Neal Browning receives a shot in the first-stage safety study clinical trial of a potential vaccine for the COVID-19 coronavirus, Monday, March 16, 2020, at the Kaiser Permanente Washington Health Research Institute in Seattle. Browning is the second patient to receive the shot in the study. (AP Photo/Ted S. Warren) Neal Browning receives a shot in the first-stage safety study clinical trial of a potential vaccine for the COVID-19 coronavirus, Monday, March 16, 2020, at the Kaiser Permanente Washington Health Research Institute in Seattle. Browning is the second patient to receive the shot in the study. (AP Photo/Ted S. Warren)
Drugmakers Expected To Pledge COVID Vaccine Safety In Effort To Diminish Fears
By Zoe Richards
09.05.20 | 2:47 pm
BETHESDA, MD - NOVEMBER 21: Nurse Floreliz Mendoza holds the syringe she has used to inject Andie Vaught, 25, with an experimental Zika vaccine as part of a clinical trial at the National Institute of Health Clinical Center in Bethesda, Maryland, November 21, 2016. This vaccine, one of about six or seven in different phases of clinical trial, is currently undergoing safety testing at three locations in the country. Instead of using dead or weakened virus to get the immune system to recognize the infection and fight it off, it uses a piece of DNA engineered to contain genes that code for proteins of the Zika virus. (Photo by Allison Shelley/For The Washington Post) BETHESDA, MD - NOVEMBER 21: Nurse Floreliz Mendoza holds the syringe she has used to inject Andie Vaught, 25, with an experimental Zika vaccine as part of a clinical trial at the National Institute of Health Clinical Center in Bethesda, Maryland, November 21, 2016. This vaccine, one of about six or seven in different phases of clinical trial, is currently undergoing safety testing at three locations in the country. Instead of using dead or weakened virus to get the immune system to recognize the infection and fight it off, it uses a piece of DNA engineered to contain genes that code for proteins of the Zika virus. (Photo by Allison Shelley/For The Washington Post)
Why Trump’s Pressure Campaign On The FDA Will Damage Any COVID-19 Vaccine To Come
By Josh Kovensky
08.24.20 | 6:05 pm
Next →
Talking Points Memo
© 2026 TPM MEDIA LLC.
Masthead Contact Privacy Policy
  • About
  • Memberships
  • Careers
  • Advertise
  • Site Status
  • FAQ
  • Newsletters
  • Pitch Us
  • Terms of Use
  • CCPA Notice